Fosun Pharmaceuticals announced that on August 31, 2026, the company repurchased 70,500 H shares through the Hong Kong Stock Exchange. The repurchase price range for each share was HK$16.01 to HK$16.05, with a total repurchase amount of HK$1,130,200. The repurchased shares are intended to be held as treasury shares. This repurchase accounted for 0.01% of the shares issued before the incident. After the repurchase, the company's H shares already issued were 540.6840 million shares, and the treasury shares were 11.5565 million shares.

Fosun Pharmaceuticals announced that on August 31, 2026, the company repurchased 70,500 H shares through the Hong Kong Stock Exchange. The repurchase price range for each share was HK$16.01 to HK$16.05, with a total repurchase amount of HK$1,130,200. The repurchased shares are intended to be held as treasury shares. This repurchase accounted for 0.01% of the shares issued before the incident. After the repurchase, the company's H shares already issued were 540.6840 million shares, and the treasury shares were 11.5565 million shares.